Key Points
- Septerna SVP Daniel Long sold 3,334 shares at an average price of $34.47, generating approximately $114,923. He retained 96,412 shares after the transaction, a 3.34% reduction in his ownership.
- Septerna shares opened at $38.76 and remain near their 12-month high of $40.63, with a market capitalization of approximately $1.75 billion. The company recently exceeded earnings and revenue expectations, reporting a quarterly loss of $0.19 per share and revenue of $26.52 million.
- Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $45.89, although ratings range from “Strong Buy” to “Sell.” Major institutional investors including Goldman Sachs and Vanguard have increased their holdings.
Septerna, Inc. (NASDAQ:SEPN - Get Free Report) SVP Daniel Long sold 3,334 shares of the firm's stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $34.47, for a total value of $114,922.98. Following the completion of the sale, the senior vice president owned 96,412 shares of the company's stock, valued at approximately $3,323,321.64. This represents a 3.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Septerna Stock Down 0.6%
SEPN stock opened at $38.76 on Thursday. Septerna, Inc. has a twelve month low of $10.62 and a twelve month high of $40.63. The stock has a market capitalization of $1.75 billion, a price-to-earnings ratio of -47.85 and a beta of 2.29. The firm's fifty day simple moving average is $34.06 and its two-hundred day simple moving average is $28.83.
Septerna (NASDAQ:SEPN - Get Free Report) last released its earnings results on Monday, May 11th. The company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.42) by $0.23. Septerna had a negative net margin of 49.88% and a negative return on equity of 12.72%. The firm had revenue of $26.52 million during the quarter, compared to analyst estimates of $16.98 million. As a group, equities research analysts expect that Septerna, Inc. will post -1.59 EPS for the current year.
Analysts Set New Price Targets
SEPN has been the subject of several recent analyst reports. Raymond James Financial boosted their target price on Septerna from $47.00 to $53.00 and gave the company a "strong-buy" rating in a research report on Monday, June 8th. HC Wainwright reissued a "buy" rating and set a $40.00 price target on shares of Septerna in a research note on Wednesday, July 1st. Guggenheim dropped their price objective on Septerna from $52.00 to $45.00 and set a "buy" rating for the company in a report on Wednesday, July 1st. Stifel Nicolaus began coverage on Septerna in a research report on Friday, May 1st. They issued a "buy" rating and a $43.00 price objective on the stock. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Septerna in a research note on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $45.89.
View Our Latest Report on Septerna
Institutional Investors Weigh In On Septerna
Several large investors have recently added to or reduced their stakes in SEPN. Goldman Sachs Group Inc. increased its position in shares of Septerna by 86.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 2,715,129 shares of the company's stock worth $75,698,000 after acquiring an additional 1,260,409 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Septerna by 7.4% in the third quarter. Vanguard Group Inc. now owns 1,518,757 shares of the company's stock valued at $28,568,000 after purchasing an additional 104,394 shares during the period. ADAR1 Capital Management LLC grew its stake in Septerna by 38.9% in the third quarter. ADAR1 Capital Management LLC now owns 1,176,491 shares of the company's stock worth $22,130,000 after purchasing an additional 329,264 shares in the last quarter. Janus Henderson Group PLC bought a new position in Septerna in the first quarter worth approximately $21,334,000. Finally, First Light Asset Management LLC increased its holdings in Septerna by 18.0% during the 1st quarter. First Light Asset Management LLC now owns 732,860 shares of the company's stock worth $17,611,000 after purchasing an additional 112,049 shares during the period.
About Septerna
(
Get Free Report)
We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
